Exhibit 31.1

                                 CERTIFICATIONS

I, Gerald Kern, certify that:

     1.   I have reviewed this annual report on Form 10-KSB/A of Meditech
          Pharmaceuticals, Inc;

     2.   Based on my knowledge, this report does not contain any untrue
          statement of a material fact or omit to state a material fact
          necessary to make the statements made, in light of the circumstances
          under which such statements were made, not misleading with respect to
          the period covered by this report;

     3.   Based on my knowledge, the financial statements, and other financial
          information included in this report, fairly present in all material
          respects the financial condition, results of operations and cash flows
          of the registrant as of, and for, the periods presented in this
          report.

     4.   The registrant's other certifying officer and I are responsible for
          establishing and maintaining disclosure controls and procedures (as
          defined in Exchange Act Rules 13a-15(e) and 15d-15(e) for the
          registrant and have:

               a.   Designed such disclosure controls and procedures, or caused
                    such disclosure controls and procedures to be designed under
                    our supervision, to ensure that material information
                    relating to the registrant, including its consolidated
                    subsidiaries, is made known to us by others within those
                    entities, particularly during the period in which this
                    report is being prepared;

               b.   Evaluated the effectiveness of the registrants' disclosure
                    controls and procedures and presented in this report our
                    conclusions about the effectiveness of the disclosure
                    controls and procedures, as of the end of the period covered
                    by this report based on such evaluation; and

               c.   Disclosed in this report any changes in the registrants'
                    internal control over financial reporting that occurred
                    during the registrants' most recent fiscal quarter (the
                    registrant's fourth fiscal quarter in case of an annual
                    report) that has materially affected, or is reasonably
                    likely to materially affect, the registrants' internal
                    control over financial reporting; and

     5.   The registrants' other certifying officer and I have disclosed, based
          on our most recent evaluation of internal control over financial
          reporting, to the registrant's auditors and the audit committee of
          registrant's board of directors (or persons performing the equivalent
          functions):

               a.   All significant deficiencies and material weaknesses in the
                    design or operation of internal control over financial
                    reporting which are reasonably likely to adversely affect
                    the registrant's ability to record, process, summarize, and
                    report financial information; and

               b.   Any fraud, whether or not material, that involves management
                    or other employees who have a significant role in the
                    registrants' internal control over financial reporting.






By:  /s/  Gerald Kern
   -------------------------------
          Gerald Kern
          Chairman and Chief Executive Officer


September 15, 2003